By mimicking the action of the GLP-1 hormone, it helps to control blood sugar levels, reduce weight, and lower the risk of cardiovascular events
GLP-1 medications deliver substantially greater weight loss: semaglutide trials showed 1015% body weight reduction over 68 weeks, and tirzepatide (a dual GLP-1/GIP agonist) demonstrated 20%+ reductions in some cohorts
Clinical verdict: The most structured non-specialist program available at scale
MeAgain publishes this page
ICYMI: GLP-1 Drugs and Muscle Loss, Inexpensive Used Cars, and June Product Deals Also last week at CR: Compact washers and dryers, and updates in CRs Price Tracker for 16 consumer products Our In Case You Missed It series highlights recent ratings, news, and investigations